 | • レポートコード：QY20ST-03002 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の抗炎症性生物製剤市場について種類別（合成型、生物型）、用途別（関節炎、呼吸器疾患、皮膚科、消化器科、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗炎症性生物製剤市場の概要 ・世界の主要地域別抗炎症性生物製剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗炎症性生物製剤市場規模2015-2026：種類別（合成型、生物型） ・世界の抗炎症性生物製剤市場規模2015-2026：用途別（関節炎、呼吸器疾患、皮膚科、消化器科、その他） ・抗炎症性生物製剤の北米市場規模2015-2020 ・抗炎症性生物製剤のヨーロッパ市場規模2015-2020 ・抗炎症性生物製剤の中国市場規模2015-2020 ・抗炎症性生物製剤の日本市場規模2015-2020 ・抗炎症性生物製剤の東南アジア市場規模2015-2020 ・抗炎症性生物製剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・抗炎症性生物製剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗炎症性生物製剤の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Anti-inflammatory Biologics Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Anti-inflammatory Biologics market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-inflammatory Biologics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-inflammatory Biologics industry.
Based on our recent survey, we have several different scenarios about the Anti-inflammatory Biologics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-inflammatory Biologics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Anti-inflammatory Biologics market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Anti-inflammatory Biologics market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Anti-inflammatory Biologics market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Anti-inflammatory Biologics market. The report also includes nautical information, where it shows Anti-inflammatory Biologics market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Anti-inflammatory Biologics market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Anti-inflammatory Biologics market.
Geographical Analysis:
Based on region, the global Anti-inflammatory Biologics market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Anti-inflammatory Biologics market are
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline
Segment by Type
Synthetic Type
Biological Type
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anti-inflammatory Biologics market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Anti-inflammatory Biologics market.
• The market share of the global Anti-inflammatory Biologics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anti-inflammatory Biologics market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anti-inflammatory Biologics market.
1 Anti-inflammatory Biologics Market Overview
1.1 Anti-inflammatory Biologics Product Scope
1.2 Anti-inflammatory Biologics Segment by Type
1.2.1 Global Anti-inflammatory Biologics Sales by Type (2020-2026)
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Anti-inflammatory Biologics Segment by Application
1.3.1 Global Anti-inflammatory Biologics Sales Comparison by Application (2020-2026)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Anti-inflammatory Biologics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anti-inflammatory Biologics Sales Growth Rate (2015-2026)
1.4.2 Global Anti-inflammatory Biologics Revenue and Growth Rate (2015-2026)
1.4.3 Global Anti-inflammatory Biologics Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anti-inflammatory Biologics Industry Impact
1.5.1 How the Covid-19 is Affecting the Anti-inflammatory Biologics Industry
1.5.1.1 Anti-inflammatory Biologics Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anti-inflammatory Biologics Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anti-inflammatory Biologics Players to Combat Covid-19 Impact
2 Anti-inflammatory Biologics Estimate and Forecast by Region
2.1 Global Anti-inflammatory Biologics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anti-inflammatory Biologics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anti-inflammatory Biologics Sales Market Share by Region (2015-2020)
2.2.2 Global Anti-inflammatory Biologics Revenue Market Share by Region (2015-2020)
2.3 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anti-inflammatory Biologics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anti-inflammatory Biologics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anti-inflammatory Biologics Estimates and Projections (2015-2026)
2.4.2 Europe Anti-inflammatory Biologics Estimates and Projections (2015-2026)
2.4.3 China Anti-inflammatory Biologics Estimates and Projections (2015-2026)
2.4.4 Japan Anti-inflammatory Biologics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anti-inflammatory Biologics Estimates and Projections (2015-2026)
2.4.6 India Anti-inflammatory Biologics Estimates and Projections (2015-2026)
3 Global Anti-inflammatory Biologics Competition Landscape by Players
3.1 Global Top Anti-inflammatory Biologics Players by Sales (2015-2020)
3.2 Global Top Anti-inflammatory Biologics Players by Revenue (2015-2020)
3.3 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2019)
3.4 Global Anti-inflammatory Biologics Average Price by Company (2015-2020)
3.5 Manufacturers Anti-inflammatory Biologics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anti-inflammatory Biologics Players (Opinion Leaders)
4 Global Anti-inflammatory Biologics Market Size by Type
4.1 Global Anti-inflammatory Biologics Historic Market Review by Type (2015-2020)
4.1.1 Global Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
4.1.2 Global Anti-inflammatory Biologics Revenue Market Share by Type (2015-2020)
4.1.3 Global Anti-inflammatory Biologics Price by Type (2014-2020)
4.2 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anti-inflammatory Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Global Anti-inflammatory Biologics Price Forecast by Type (2021-2026)
5 Global Anti-inflammatory Biologics Market Size by Application
5.1 Global Anti-inflammatory Biologics Historic Market Review by Application (2015-2020)
5.1.1 Global Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
5.1.2 Global Anti-inflammatory Biologics Revenue Market Share by Application (2015-2020)
5.1.3 Global Anti-inflammatory Biologics Price by Application (2015-2020)
5.2 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anti-inflammatory Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-inflammatory Biologics Price Forecast by Application (2021-2026)
3 North America Anti-inflammatory Biologics Market Facts & Figures
3.2 North America Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
3.3 North America Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
3.4 North America Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
4 Europe Anti-inflammatory Biologics Market Facts & Figures
4.2 Europe Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
4.3 Europe Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
4.4 Europe Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
5 China Anti-inflammatory Biologics Market Facts & Figures
5.2 China Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
5.3 China Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
5.4 China Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
6 Japan Anti-inflammatory Biologics Market Facts & Figures
6.2 Japan Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
6.3 Japan Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
6.4 Japan Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
7 Southeast Asia Anti-inflammatory Biologics Market Facts & Figures
7.2 Southeast Asia Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
8 India Anti-inflammatory Biologics Market Facts & Figures
8.2 India Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
8.3 India Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
8.4 India Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anti-inflammatory Biologics Business
12.1 AbbVie
12.1.1 AbbVie Anti-inflammatory Biologics Corporation Information
12.1.2 AbbVie Anti-inflammatory Biologics Business Overview and Total Revenue
12.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Anti-inflammatory Biologics Products Offered
12.1.5 AbbVie Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Anti-inflammatory Biologics Corporation Information
12.2.2 Johnson & Johnson Anti-inflammatory Biologics Business Overview and Total Revenue
12.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Anti-inflammatory Biologics Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Amgen Inc
12.3.1 Amgen Inc Anti-inflammatory Biologics Corporation Information
12.3.2 Amgen Inc Anti-inflammatory Biologics Business Overview and Total Revenue
12.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen Inc Anti-inflammatory Biologics Products Offered
12.3.5 Amgen Inc Recent Development
12.4 AstraZeneca PLC
12.4.1 AstraZeneca PLC Anti-inflammatory Biologics Corporation Information
12.4.2 AstraZeneca PLC Anti-inflammatory Biologics Business Overview and Total Revenue
12.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca PLC Anti-inflammatory Biologics Products Offered
12.4.5 AstraZeneca PLC Recent Development
12.5 Pfizer, Inc
12.5.1 Pfizer, Inc Anti-inflammatory Biologics Corporation Information
12.5.2 Pfizer, Inc Anti-inflammatory Biologics Business Overview and Total Revenue
12.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer, Inc Anti-inflammatory Biologics Products Offered
12.5.5 Pfizer, Inc Recent Development
12.6 Novartis
12.6.1 Novartis Anti-inflammatory Biologics Corporation Information
12.6.2 Novartis Anti-inflammatory Biologics Business Overview and Total Revenue
12.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Anti-inflammatory Biologics Products Offered
12.6.5 Novartis Recent Development
12.7 Roche
12.7.1 Roche Anti-inflammatory Biologics Corporation Information
12.7.2 Roche Anti-inflammatory Biologics Business Overview and Total Revenue
12.7.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Anti-inflammatory Biologics Products Offered
12.7.5 Roche Recent Development
12.8 Sun Pharmaceutical Industries Ltd
12.8.1 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Corporation Information
12.8.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Business Overview and Total Revenue
12.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Products Offered
12.8.5 Sun Pharmaceutical Industries Ltd Recent Development
12.9 Sanofi
12.9.1 Sanofi Anti-inflammatory Biologics Corporation Information
12.9.2 Sanofi Anti-inflammatory Biologics Business Overview and Total Revenue
12.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Anti-inflammatory Biologics Products Offered
12.9.5 Sanofi Recent Development
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Anti-inflammatory Biologics Corporation Information
12.10.2 GlaxoSmithKline Anti-inflammatory Biologics Business Overview and Total Revenue
12.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GlaxoSmithKline Anti-inflammatory Biologics Products Offered
12.10.5 GlaxoSmithKline Recent Development
13 Anti-inflammatory Biologics Manufacturing Cost Analysis
13.1 Anti-inflammatory Biologics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-inflammatory Biologics
13.4 Anti-inflammatory Biologics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-inflammatory Biologics Distributors List
14.3 Anti-inflammatory Biologics Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-inflammatory Biologics Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Anti-inflammatory Biologics Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anti-inflammatory Biologics Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anti-inflammatory Biologics Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anti-inflammatory Biologics Players to Combat Covid-19 Impact
Table 8. Global Market Anti-inflammatory Biologics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anti-inflammatory Biologics Sales (K MT) by Region (2015-2020)
Table 10. Global Anti-inflammatory Biologics Sales Market Share by Region (2015-2020)
Table 11. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anti-inflammatory Biologics Revenue Share by Region (2015-2020)
Table 13. Global Anti-inflammatory Biologics Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Anti-inflammatory Biologics Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anti-inflammatory Biologics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anti-inflammatory Biologics Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anti-inflammatory Biologics (K MT) of Key Companies (2015-2020)
Table 18. Global Anti-inflammatory Biologics Sales Share by Company (2015-2020)
Table 19. Global Anti-inflammatory Biologics Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anti-inflammatory Biologics Revenue Share by Company (2015-2020)
Table 21. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2019)
Table 22. Global Anti-inflammatory Biologics Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Anti-inflammatory Biologics Manufacturing Sites and Area Served
Table 24. Manufacturers Anti-inflammatory Biologics Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anti-inflammatory Biologics Players
Table 27. Global Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 28. Global Anti-inflammatory Biologics Sales Share by Type (2015-2020)
Table 29. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anti-inflammatory Biologics Price (K MT) by Type (2015-2020)
Table 31. Global Anti-inflammatory Biologics Sales Share by Type (2021-2026)
Table 32. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anti-inflammatory Biologics Revenue Share by Type (2021-2026)
Table 34. Global Anti-inflammatory Biologics Price (K MT) by Type (2021-2026)
Table 35. Global Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 36. Global Anti-inflammatory Biologics Sales Share by Application (2015-2020)
Table 37. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anti-inflammatory Biologics Price (K MT) by Application (2015-2020)
Table 39. Global Anti-inflammatory Biologics Sales (K MT) by Application (2021-2026)
Table 40. Global Anti-inflammatory Biologics Sales Share by Application (2021-2026)
Table 41. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anti-inflammatory Biologics Revenue Share by Application (2021-2026)
Table 43. Global Anti-inflammatory Biologics Price (K MT) by Application (2021-2026)
Table 44. United States Anti-inflammatory Biologics Sales (K MT) by Company (2015-2020)
Table 45. United States Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 46. United States Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 47. United States Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 48. United States Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 49. United States Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 50. Europe Anti-inflammatory Biologics Sales (K MT) by Company (2015-2020)
Table 51. Europe Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 52. Europe Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 53. Europe Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 54. Europe Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 55. Europe Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 56. China Anti-inflammatory Biologics Sales (K MT) by Company (2015-2020)
Table 57. China Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 58. China Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 59. China Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 60. China Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 61. China Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 62. Japan Anti-inflammatory Biologics Sales (K MT) by Company (2015-2020)
Table 63. Japan Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 64. Japan Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 65. Japan Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 66. Japan Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 67. Japan Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anti-inflammatory Biologics Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 74. India Anti-inflammatory Biologics Sales (K MT) by Company (2015-2020)
Table 75. India Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 76. India Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 77. India Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 78. India Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 79. India Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. AbbVie Anti-inflammatory Biologics Product
Table 84. AbbVie Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Anti-inflammatory Biologics Product
Table 89. Johnson & Johnson Recent Development
Table 90. Amgen Inc Corporation Information
Table 91. Amgen Inc Description and Business Overview
Table 92. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Inc Anti-inflammatory Biologics Product
Table 94. Amgen Inc Recent Development
Table 95. AstraZeneca PLC Corporation Information
Table 96. AstraZeneca PLC Description and Business Overview
Table 97. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. AstraZeneca PLC Anti-inflammatory Biologics Product
Table 99. AstraZeneca PLC Recent Development
Table 100. Pfizer, Inc Corporation Information
Table 101. Pfizer, Inc Description and Business Overview
Table 102. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Pfizer, Inc Anti-inflammatory Biologics Product
Table 104. Pfizer, Inc Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Novartis Anti-inflammatory Biologics Product
Table 109. Novartis Recent Development
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Roche Anti-inflammatory Biologics Product
Table 114. Roche Recent Development
Table 115. Sun Pharmaceutical Industries Ltd Corporation Information
Table 116. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 118. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product
Table 119. Sun Pharmaceutical Industries Ltd Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Sanofi Description and Business Overview
Table 123. Sanofi Anti-inflammatory Biologics Product
Table 124. Sanofi Recent Development
Table . GlaxoSmithKline Corporation Information
Table . GlaxoSmithKline Description and Business Overview
Table . GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . GlaxoSmithKline Anti-inflammatory Biologics Product
Table . GlaxoSmithKline Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Anti-inflammatory Biologics Distributors List
Table 133. Anti-inflammatory Biologics Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-inflammatory Biologics Product Picture
Figure 2. Global Anti-inflammatory Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-inflammatory Biologics Market Share by Application in 2020 & 2026
Figure 6. Arthritis Examples
Figure 7. Respiratory Diseases Examples
Figure 8. Dermatology Examples
Figure 9. Gastroenterology Examples
Figure 10. Others Examples
Figure 11. Global Anti-inflammatory Biologics Sales (K MT) Growth Rate (2015-2026)
Figure 12. Global Anti-inflammatory Biologics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Anti-inflammatory Biologics Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global Anti-inflammatory Biologics Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Anti-inflammatory Biologics Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Anti-inflammatory Biologics Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Anti-inflammatory Biologics Sales (K MT) Growth Rate (2015-2026)
Figure 18. Europe Anti-inflammatory Biologics Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Anti-inflammatory Biologics Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Anti-inflammatory Biologics Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Anti-inflammatory Biologics Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Anti-inflammatory Biologics Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Anti-inflammatory Biologics Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Anti-inflammatory Biologics Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Anti-inflammatory Biologics Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Anti-inflammatory Biologics Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Anti-inflammatory Biologics Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Anti-inflammatory Biologics Players Market Share by Revenue in Anti-inflammatory Biologics 2015 & 2019
Figure 29. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Anti-inflammatory Biologics Revenue Share by Type (2015-2020)
Figure 31. Global Anti-inflammatory Biologics Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Anti-inflammatory Biologics Revenue Share by Application (2015-2020)
Figure 33. Global Anti-inflammatory Biologics Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 35. United States Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 36. Europe Anti-inflammatory Biologics Sales Market Share by Company in 2019
Figure 37. Europe Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 38. Europe Anti-inflammatory Biologics Sales Market Share by Application in 2019
Figure 39. China Anti-inflammatory Biologics Sales Market Share by Company in 2019
Figure 40. China Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 41. China Anti-inflammatory Biologics Sales Market Share by Application in 2019
Figure 42. Japan Anti-inflammatory Biologics Sales Market Share by Company in 2019
Figure 43. Japan Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 44. Japan Anti-inflammatory Biologics Sales Market Share by Application in 2019
Figure 45. Southeast Asia Anti-inflammatory Biologics Sales Market Share by Company in 2019
Figure 46. Southeast Asia Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 47. Southeast Asia Anti-inflammatory Biologics Sales Market Share by Application in 2019
Figure 48. India Anti-inflammatory Biologics Sales Market Share by Company in 2019
Figure 49. India Anti-inflammatory Biologics Sales Market Share by Type in 2019
Figure 50. India Anti-inflammatory Biologics Sales Market Share by Application in 2019
Figure 51. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AstraZeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Sun Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Anti-inflammatory Biologics
Figure 63. Manufacturing Process Analysis of Anti-inflammatory Biologics
Figure 64. Anti-inflammatory Biologics Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
自己免疫疾患治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 111090 million by 2025, from USD 101510 million in 2019. The Autoimm…- プライバシー保護フィルムの世界市場レポート2020 Market Analysis and Insights: Global Anti-spy Film Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 …
- トップ反射防止コーティング剤（TARC）の世界市場レポート2020 A recently published report by QY Research titled Global Top Anti-Reflective Coatings (TARC) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- 免疫抑制剤の世界市場レポート2020 A recently published report by QY Research titled Global Immune Anti-Inhibitor Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…
- 反射防止（AR）・指紋防止（AF）ナノコーティングの世界市場レポート2020 A recently published report by QY Research titled Global Anti-reflective (AR) and Anti-fingerprint (AF) Nanocoating Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research rep…